EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy

Wenshe Sun iD, Shaowei Xie iD, Shi Feng Liu, Xiaokun Hu, Dongming Xing

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s453265 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Wenshe Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Hospital of Qingdao University, Qingdao, 266071, People's Republic of China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Typical physiological characteristics of tumors, such as weak acidity, low oxygen content, and upregulation of certain enzymes in the tumor microenvironment (TME), provide survival advantages when exposed to targeted attacks by drugs and responsive nanomedicines. Consequently, cancer treatment has significantly progressed in recent years. However, the evolution and adaptation of tumor characteristics still pose many challenges for current treatment methods. Therefore, efficient and precise cancer treatments require an understanding of the heterogeneity degree of various factors in cancer cells during tumor evolution to exploit the typical TME characteristics and manage the mutation process. The highly heterogeneous tumor and infiltrating stromal cells, immune cells, and extracellular components collectively form a unique TME, which plays a crucial role in tumor malignancy, including proliferation, invasion, metastasis, and immune escape. Therefore, the development of new treatment methods that can adapt to the evolutionary characteristics of tumors has become an intense focus in current cancer treatment research. This paper explores the latest understanding of cancer evolution, focusing on how tumors use new antigens to shape their "new faces"; how immune system cells, such as cytotoxic T cells, regulatory T cells, macrophages, and natural killer cells, help tumors become "invisible", that is, immune escape; whether the diverse cancer-associated fibroblasts provide support and coordination for tumors; and whether it is possible to attack tumors in reverse. This paper discusses the limitations of targeted therapy driven by tumor evolution factors and explores future strategies and the potential of intelligent nanomedicines, including the systematic coordination of tumor evolution factors and adaptive methods, to meet this therapeutic challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentImmunotherapyNeoplasmsHumansNanomedicineAnimalsNanoparticlesAntineoplastic Agents

Stichwörter der Autor:innen

fibroblastsimmune cellssmart nanomedicinetumor evolution

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • The Affiliated Hospital of Qingdao University, Qingdao, 266071, People's Republic of China.
  • Qingdao Cancer Institute, Qingdao University, Qingdao, 266071, People's Republic of China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, People's Republic of China.
  • Department of Ultrasound, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, People's Republic of China.

ORCID-Profile: Wenshe Sun, Shaowei Xie

Zitieren

APA

Sun, W., Xie, S., Liu, S. F., Hu, X., & Xing, D. (2024). Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s453265

Vancouver

Sun W, Xie S, Liu SF, Hu X, Xing D. Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s453265

BibTeX
@article{Sun2024,
  author = {Sun, Wenshe and Xie, Shaowei and Liu, Shi Feng and Hu, Xiaokun and Xing, Dongming},
  title = {Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s453265}
}
Kostenlos starten →